The launch of Ontario’s vehicle innovation network signals readiness for next-generation auto solutions, Alberta invests tens of millions of dollars to fund vaccine research and manufacturing capacity, research activity continues to grow at colleges and institutes across Canada, and more.
Topic: Canadian biomanufacturing
A new biomanufacturing partnership will boost Canada’s manufacturing capacity, projecting pandemic-induced revenue loss for Canada’s universities, IPIC makes pre-budget recommendations, and more.
Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.
Minister Champagne announces construction of NRC’s vaccine plant in Montreal is complete, Concordia gets go-ahead for a new school of interdisciplinary health, NISC receives quantum research funding to improve online communication security, and more.
Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.